All Stories

  1. Oxidative and Nitrosative Stress in the Pathogenesis of Obstructive Lung Diseases of Increasing Severity
  2. The Nitric Oxide View: Perspectives and Applications
  3. Mepolizumab reduces nasal symptoms in asthmatic patients with chronic rhino-sinusitis and nasal polyposis: a 12 months real-life study
  4. Portable oxygen concentrator vesus oxygen cylinder in chronic lung disease: patient preferences and psychological implications
  5. Metabolomics of Exhaled Breath Condensate by Nuclear Magnetic Resonance Spectroscopy and Mass Spectrometry: A Methodological Approach
  6. A transcutaneous carbon dioxide monitor is a useful tool with known caveats
  7. Comparison of three different exhaled nitric oxide analyzers in asthma and COPD
  8. Association between exhaled nitric oxide and nasal polyposisin severe asthma
  9. Is there a role for biomarkers in pulmonary rehabilitation?
  10. Patient considerations in the treatment of COPD: focus on the new combination inhaler fluticasone furoate/umeclidinium/vilanterol
  11. Left ventricular hypertrophy as protective factor after bypass grafting
  12. Clinical and Inflammatory Phenotyping: Can Electronic Nose and NMR-based Metabolomics Work at the Bedside?
  13. Long-term Effects of Vasodilators in Combined Pulmonary Fibrosis and Emphysema with Severe Pulmonary Hypertension: A Case Report
  14. Differential diagnosis between newly diagnosed asthma and COPD using exhaled breath condensate metabolomics: a pilot study
  15. Description of a new rare alpha-1 antitrypsin mutation in Naples (Italy): PI*M S-Napoli
  16. Long-term effect of weight loss induced by bariatric surgery on asthma control and health related quality of life in asthmatic patients with severe obesity: A pilot study
  17. Chronic Obstructive Pulmonary Disease in Farmers
  18. Biomarkers in allergic asthma: Which matrix should we use?
  19. Nasal nitric oxide as biomarker in the evaluation and management of chronic rhino-sinusitis with nasal polyposis
  20. Metabolomics of exhaled breath condensate: a means for phenotyping respiratory diseases?
  21. Coexistence of obesity and asthma determines a distinct respiratory metabolic phenotype
  22. Recent Advances on Nitric Oxide in the Upper Airways
  23. Fractional exhaled nitric oxide-measuring devices: technology update
  24. Meet Our Editorial Board Member:
  25. Metabolomics of chronic obstructive pulmonary disease and obstructive sleep apnea syndrome: a comment
  26. Low alveolar and bronchial nitric oxide in severe uncomplicated obesity
  27. Echocardiographic findings and plasma endothelin-1 levels in obese patients with and without obstructive sleep apnea
  28. Relationship between echocardiographic assessment and plasma endothelin-1 levels in obese patients with or without obstructive sleep apnea
  29. Extended analysis of exhaled and nasal nitric oxide for the evaluation of chronic cough
  30. Smoking Habit in Severe Obese after bariatric procedures
  31. Inflammatory metabolites in exhaled breath condensate characterize the obese respiratory phenotype
  32. NMR Metabolomic Analysis of Exhaled Breath Condensate of Asthmatic Patients at Two Different Temperatures
  33. Clinical application of nasal nitric oxide measurement in pediatric airway diseases
  34. Nocturnal continuous positive airway pressure in severe non-apneic asthma. A pilot study
  35. Exhaled nasal nitric oxide during humming: potential clinical tool in sinonasal disease?
  36. Separating Smoking-Related Diseases Using NMR-Based Metabolomics of Exhaled Breath Condensate
  37. Right heart and pulmonary thromboembolism from extensive splanchnic vein thrombosis after splenectomy for myeloproliferative disease
  38. Obesity Duration Is Associated to Pulmonary Function Impairment in Obese Subjects
  39. Measurement of nasal nitric oxide by hand-held and stationary devices
  40. Exploring Airway Diseases by NMR-Based Metabonomics: A Review of Application to Exhaled Breath Condensate
  41. Hand-held nitric oxide sensor NIOX MINO®for the monitoring of respiratory disorders
  42. Nasal nitric oxide
  43. Endothelin-1 in acute pulmonary embolism
  44. Exhaled nitric oxide and other major exhaled compounds for the diagnosis of metabolic diseases
  45. Early treatment with noninvasive positive pressure ventilation prolongs survival in Amyotrophic Lateral Sclerosis patients with nocturnal respiratory insufficiency
  46. Exhaled and arterial levels of endothelin-1 are increased and correlate with pulmonary systolic pressure in COPD with pulmonary hypertension
  47. Exhaled nitric oxide monitoring in COPD using a portable analyzer
  48. Correlation of Transabdominal Sonographic and Cystoscopic Findings in the Diagnosis of Focal Abnormalities of the Urinary Bladder Wall
  49. Evaluation of a transcutaneous carbon dioxide monitor in severe obesity
  50. Weight loss and asthma control in severely obese asthmatic females
  51. Long-term effect of bariatric surgery on respiratory function in severe uncomplicated obesity
  52. Exhaled nitric oxide in severe obesity: Effect of weight loss
  53. Nitric oxide in upper airways inflammatory diseases
  54. Effect of Bariatric Surgery on the Six-Minute Walk Test in Severe Uncomplicated Obesity
  55. Nasal nitric oxide in experimental rhinovirus infection
  56. Association of Adams-Oliver syndrome with pulmonary arterio-venous malformation in the same family: A further support to the vascular hypothesis
  57. Orthodeoxia without Platypnea from Interatrial Defect Associated with Persistent Left Superior Vena cava in the Absence of Pulmonary Hypertension
  58. Transient Decrease of Exhaled Nitric Oxide after Acute Exposure to Passive Smoke in Healthy Subjects
  59. PASSIVE SMOKE AND EXHALED NITRIC OXIDE
  60. Exhaled nitric oxide after inhalation of isotonic and hypotonic solutions in healthy subjects
  61. Exhaled nitric oxide after inhalation of isotonic and hypotonic solutions in healthy subjects
  62. Abnormalities of Renal Endothelin during Acute Exacerbation in Chronic Obstructive Pulmonary Disease
  63. Effects of an NO-Synthase Inhibitor L-NMMA in the Hepatopulmonary Syndrome
  64. Endothelin Abnormalities in Patients With Pulmonary Embolism